The aim of this proposal is to create a multiannual joint programme of collaboration between research-intensive non-commercial (academic) and commercial (industry) organisations to increase knowledge on the effects of colostrum-based neutraceuticals on functional gastrointestinal disorders (FGID). Functional gastrointestinal disorders such as irritable bowel syndrome represent well-known issues, y ...